A Warnke

Summary

Affiliation: SocraTec R and D
Country: Germany

Publications

  1. ncbi request reprint Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources
    A Warnke
    SocraTec R and D GmbH, Oberursel, Germany
    Int J Clin Pharmacol Ther 47:405-12. 2009
  2. ncbi request reprint [Importance of the formulation for a chronopharmacologically optimised way of pain therapy. Results of a comparative bioavailability study of tramadol extended-release capsules after single-dose evening versus morning administration]
    A Warnke
    SocraTec R and D GmbH, Oberursel
    MMW Fortschr Med 150:36-42. 2008

Detail Information

Publications2

  1. ncbi request reprint Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources
    A Warnke
    SocraTec R and D GmbH, Oberursel, Germany
    Int J Clin Pharmacol Ther 47:405-12. 2009
    ..Tramadol is currently one of the most frequently used opioid analgesics in the world...
  2. ncbi request reprint [Importance of the formulation for a chronopharmacologically optimised way of pain therapy. Results of a comparative bioavailability study of tramadol extended-release capsules after single-dose evening versus morning administration]
    A Warnke
    SocraTec R and D GmbH, Oberursel
    MMW Fortschr Med 150:36-42. 2008
    ..Objective of this study was to investigate the rate and extent of tramadol bioavailability following evening versus morning administration...